These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 7042080)
1. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells. White EL; Shaddix SC; Brockman RW; Bennett LL Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. Brockman RW; Cheng YC; Schabel FM; Montgomery JA Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636 [TBL] [Abstract][Full Text] [Related]
3. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase. Helland S; Ueland PM Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909 [TBL] [Abstract][Full Text] [Related]
4. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate. Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752 [TBL] [Abstract][Full Text] [Related]
5. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells. Cass CE; Selner M; Phillips JR Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904 [TBL] [Abstract][Full Text] [Related]
6. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Tseng WC; Derse D; Cheng YC; Brockman RW; Bennett LL Mol Pharmacol; 1982 Mar; 21(2):474-7. PubMed ID: 7048062 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin. Cass CE; Au-Yeung TH Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095 [TBL] [Abstract][Full Text] [Related]
8. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells. Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin. LePage GA; Worth LS; Kimball AP Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595 [TBL] [Abstract][Full Text] [Related]
10. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells. LePage GA Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902 [TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole. Sato A; Montgomery JA; Cory JG Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198 [TBL] [Abstract][Full Text] [Related]
12. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Müller WE; Rohde HJ; Beyer R; Maidhof A; Lachmann M; Taschner H; Kahn RK Cancer Res; 1975 Aug; 35(8):2160-8. PubMed ID: 1149031 [TBL] [Abstract][Full Text] [Related]
13. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity. Fridland A Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture. Cass CE; Tan TH; Selner M Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484 [TBL] [Abstract][Full Text] [Related]
15. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388. Avramis VI; Plunkett W Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells. Allaudeen HS; Kozarich JW; Sartorelli AC Nucleic Acids Res; 1982 Feb; 10(4):1379-87. PubMed ID: 6175955 [TBL] [Abstract][Full Text] [Related]
17. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity. Kufe DW; Major PP; Munroe D; Egan M; Herrick D Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus. Ono K; Ohashi A; Yamamoto A; Matsukage A; Takahasi T; Saneyoshi M; Ueda T Cancer Res; 1979 Nov; 39(11):4673-80. PubMed ID: 91427 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells. Helland S; Ueland PM Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972 [TBL] [Abstract][Full Text] [Related]
20. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine. Helland S; Ueland PM Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]